Benjamin Paluch

Stock Analyst at Roth MKM

(1.34)

# 3,579

Out of 5,041 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$43.67	+48.84%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$8.80	+93.18%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$7.82	+27.88%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $43.67

Upside: +48.84%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $8.80

Upside: +93.18%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $7.82

Upside: +27.88%